Medicure Inc. (MPH.V)
CAD 0.9
(0.0%)
CAD 0.9
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.09 CAD | -167.92% |
| 2022 | 0.13 CAD | 283.36% |
| 2021 | -0.07 CAD | 88.92% |
| 2020 | -0.64 CAD | 51.52% |
| 2019 | -1.32 CAD | -628.0% |
| 2018 | 0.25 CAD | -91.01% |
| 2017 | 2.78 CAD | 54.44% |
| 2016 | 1.80 CAD | 1400.0% |
| 2015 | 0.12 CAD | -20.0% |
| 2014 | 0.15 CAD | 215.38% |
| 2013 | -0.13 CAD | 38.1% |
| 2012 | -0.21 CAD | -110.55% |
| 2011 | 1.99 CAD | 965.22% |
| 2010 | -0.23 CAD | 64.06% |
| 2009 | -0.64 CAD | 58.17% |
| 2008 | -1.53 CAD | 77.7% |
| 2007 | -6.86 CAD | -51.43% |
| 2006 | -4.53 CAD | -79.76% |
| 2005 | -2.52 CAD | 24.55% |
| 2004 | -3.34 CAD | -107.45% |
| 2003 | -1.61 CAD | 4.73% |
| 2002 | -1.69 CAD | 19.52% |
| 2001 | -2.10 CAD | 30.0% |
| 2000 | -3.00 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.00 CAD | 103.27% |
| 2024 Q2 | -0.12 CAD | -2548.98% |
| 2023 Q2 | 0.02 CAD | -14.18% |
| 2023 FY | - CAD | -167.92% |
| 2023 Q1 | 0.03 CAD | -36.34% |
| 2023 Q3 | 0.01 CAD | -66.94% |
| 2023 Q4 | -0.15 CAD | -1975.0% |
| 2022 Q4 | 0.04 CAD | -59.73% |
| 2022 Q3 | 0.11 CAD | 265.17% |
| 2022 Q2 | -0.07 CAD | -233.2% |
| 2022 Q1 | 0.05 CAD | -73.68% |
| 2022 FY | - CAD | 283.36% |
| 2021 Q2 | -0.06 CAD | 37.7% |
| 2021 Q4 | 0.19 CAD | 305.85% |
| 2021 Q1 | -0.10 CAD | 76.19% |
| 2021 FY | - CAD | 88.92% |
| 2021 Q3 | -0.09 CAD | -48.15% |
| 2020 Q3 | -0.10 CAD | -5555.56% |
| 2020 FY | - CAD | 51.52% |
| 2020 Q1 | -0.14 CAD | 86.41% |
| 2020 Q2 | 0.00 CAD | 101.29% |
| 2020 Q4 | -0.42 CAD | -327.7% |
| 2019 Q1 | -0.18 CAD | -286.34% |
| 2019 FY | - CAD | -628.0% |
| 2019 Q2 | -0.06 CAD | 65.28% |
| 2019 Q3 | -0.04 CAD | 35.68% |
| 2019 Q4 | -1.03 CAD | -2462.19% |
| 2018 Q3 | -0.03 CAD | -134.6% |
| 2018 FY | - CAD | -91.01% |
| 2018 Q1 | 0.09 CAD | -80.43% |
| 2018 Q4 | 0.10 CAD | 379.19% |
| 2018 Q2 | 0.10 CAD | 11.11% |
| 2017 Q3 | -0.28 CAD | -411.11% |
| 2017 FY | - CAD | 54.44% |
| 2017 Q1 | -0.33 CAD | -1480.75% |
| 2017 Q4 | 0.46 CAD | 264.29% |
| 2017 Q2 | 0.09 CAD | 127.27% |
| 2016 Q3 | 0.13 CAD | 333.33% |
| 2016 Q2 | 0.03 CAD | -40.0% |
| 2016 FY | - CAD | 1400.0% |
| 2016 Q1 | 0.05 CAD | -54.55% |
| 2016 Q4 | 0.02 CAD | -81.62% |
| 2015 Q2 | 0.03 CAD | 200.0% |
| 2015 Q4 | 0.11 CAD | 554.55% |
| 2015 Q1 | 0.01 CAD | 0.0% |
| 2015 FY | - CAD | -20.0% |
| 2015 Q3 | -0.02 CAD | -180.67% |
| 2014 Q3 | 0.11 CAD | 282.12% |
| 2014 Q2 | -0.06 CAD | -704.0% |
| 2014 Q1 | 0.01 CAD | 125.06% |
| 2014 FY | - CAD | 215.38% |
| 2013 Q2 | -0.06 CAD | 32.13% |
| 2013 FY | - CAD | 38.1% |
| 2013 Q4 | -0.04 CAD | 3.16% |
| 2013 Q3 | -0.04 CAD | 31.33% |
| 2013 Q1 | -0.09 CAD | -118.27% |
| 2012 Q1 | -0.03 CAD | -132.11% |
| 2012 Q2 | - CAD | 100.0% |
| 2012 Q3 | -0.02 CAD | 0.0% |
| 2012 Q4 | -0.04 CAD | -66.67% |
| 2012 FY | - CAD | -110.55% |
| 2011 Q2 | - CAD | -100.0% |
| 2011 Q3 | 2.25 CAD | 0.0% |
| 2011 Q4 | 0.09 CAD | -96.0% |
| 2011 Q1 | 0.15 CAD | 0.0% |
| 2011 FY | - CAD | 965.22% |
| 2010 Q3 | -0.20 CAD | 0.0% |
| 2010 Q4 | 0.15 CAD | 175.0% |
| 2010 FY | - CAD | 64.06% |
| 2010 Q1 | -0.24 CAD | -1082.27% |
| 2010 Q2 | - CAD | 100.0% |
| 2009 Q2 | - CAD | 100.0% |
| 2009 Q3 | -0.22 CAD | 0.0% |
| 2009 Q4 | -0.02 CAD | 90.77% |
| 2009 FY | - CAD | 58.17% |
| 2009 Q1 | -0.42 CAD | 47.5% |
| 2008 Q4 | -0.80 CAD | -128.57% |
| 2008 Q3 | -0.35 CAD | 0.0% |
| 2008 FY | - CAD | 77.7% |
| 2008 Q1 | -2.61 CAD | -28.57% |
| 2008 Q2 | - CAD | 100.0% |
| 2007 Q4 | -2.03 CAD | -4.64% |
| 2007 Q2 | - CAD | 100.0% |
| 2007 Q1 | -1.13 CAD | -18.95% |
| 2007 FY | - CAD | -51.43% |
| 2007 Q3 | -1.94 CAD | 0.0% |
| 2006 Q1 | -0.53 CAD | 28.38% |
| 2006 Q4 | -0.95 CAD | -86.27% |
| 2006 Q2 | - CAD | 100.0% |
| 2006 Q3 | -0.51 CAD | 0.0% |
| 2006 FY | - CAD | -79.76% |
| 2005 Q3 | -0.86 CAD | 0.0% |
| 2005 Q4 | -0.74 CAD | 13.95% |
| 2005 FY | - CAD | 24.55% |
| 2005 Q1 | -0.86 CAD | -4.88% |
| 2005 Q2 | - CAD | 100.0% |
| 2004 Q4 | -0.82 CAD | -38.98% |
| 2004 FY | - CAD | -107.45% |
| 2004 Q2 | - CAD | 100.0% |
| 2004 Q3 | -0.59 CAD | 0.0% |
| 2004 Q1 | -0.35 CAD | 7.89% |
| 2003 FY | - CAD | 4.73% |
| 2003 Q1 | -0.37 CAD | 22.92% |
| 2003 Q2 | - CAD | 100.0% |
| 2003 Q4 | -0.38 CAD | -2.7% |
| 2003 Q3 | -0.37 CAD | 0.0% |
| 2002 Q3 | -0.49 CAD | 0.0% |
| 2002 FY | - CAD | 19.52% |
| 2002 Q4 | -0.48 CAD | 2.04% |
| 2001 FY | - CAD | 30.0% |
| 2000 FY | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -0.02 CAD | -294.196% |
| CanadaBis Capital Inc. | 0.03 CAD | 372.531% |
| Decibel Cannabis Company Inc. | -0.00 CAD | -1953.488% |
| Delivra Health Brands Inc. | 0.00 CAD | 2948.387% |
| Entourage Health Corp. | -0.15 CAD | 41.133% |
| Lifeist Wellness Inc. | -0.58 CAD | 84.776% |
| Cannara Biotech Inc. | 0.08 CAD | 213.496% |
| PharmaCielo Ltd. | -0.10 CAD | 11.7% |
| Rubicon Organics Inc. | -0.03 CAD | -173.375% |
| BioSyent Inc. | 0.54 CAD | 116.352% |
| Voyageur Pharmaceuticals Ltd. | -0.01 CAD | -725.234% |